Keybank National Association Edwards Lifesciences Corp Transaction History

Keybank National Association

$25.5 Billion
Q3 2024

A detailed history of Keybank National Association transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Keybank National Association holds 44,227 shares of EW stock, worth $3.36 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

44,227

Previous 46,365 4.61%

Holding current value

$3.36 Million

Previous $4.28 Million 31.85%

% of portfolio

0.01%

Previous 0.02%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$59.7 - $93.78 $127,638 - $200,501	-2,138 Reduced 4.61%	44,227 $2.92 Million
Q2 2024 Jul 31, 2024	SELL	$84.3 - $94.31 $205,186 - $229,550	-2,434 Reduced 4.99%	46,365 $4.28 Million
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $349,642 - $460,599	4,820 Added 10.96%	48,799 $4.66 Million
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $87,443 - $110,185	-1,417 Reduced 3.12%	43,979 $3.35 Million
Q3 2023 Nov 08, 2023	SELL	$69.28 - $93.38 $392,609 - $529,184	-5,667 Reduced 11.1%	45,396 $3.15 Million
Q2 2023 Aug 01, 2023	BUY	$81.41 - $94.33 $393,617 - $456,085	4,835 Added 10.46%	51,063 $4.82 Million
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $545,365 - $620,641	7,344 Added 18.89%	46,228 $3.82 Million
Q4 2022 Jan 31, 2023	SELL	$68.3 - $87.44 $261,247 - $334,458	-3,825 Reduced 8.96%	38,884 $2.9 Million
Q3 2022 Oct 27, 2022	SELL	$82.37 - $107.29 $162,433 - $211,575	-1,972 Reduced 4.41%	42,709 $3.53 Million
Q2 2022 Aug 08, 2022	BUY	$86.5 - $128.27 $67,383 - $99,922	779 Added 1.77%	44,681 $4.25 Million
Q1 2022 Apr 28, 2022	SELL	$101.96 - $128.34 $231,551 - $291,460	-2,271 Reduced 4.92%	43,902 $5.17 Million
Q4 2021 Feb 07, 2022	BUY	$106.37 - $130.68 $157,746 - $193,798	1,483 Added 3.32%	46,173 $5.98 Million
Q3 2021 Nov 08, 2021	SELL	$102.91 - $122.75 $804,859 - $960,027	-7,821 Reduced 14.89%	44,690 $5.06 Million
Q2 2021 Aug 12, 2021	SELL	$83.84 - $104.76 $482,583 - $602,998	-5,756 Reduced 9.88%	52,511 $5.44 Million
Q1 2021 May 07, 2021	SELL	$78.68 - $90.67 $85,682 - $98,739	-1,089 Reduced 1.83%	58,267 $4.87 Million
Q4 2020 Feb 09, 2021	SELL	$71.69 - $91.23 $73,769 - $93,875	-1,029 Reduced 1.7%	59,356 $5.42 Million
Q3 2020 Oct 29, 2020	BUY	$67.19 - $87.44 $313,575 - $408,082	4,667 Added 8.38%	60,385 $4.82 Million
Q2 2020 Aug 10, 2020	BUY	$57.54 - $76.95 $2.14 Million - $2.86 Million	37,148 Added 200.04%	55,718 $3.85 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $36,215 - $55,971	-691 Reduced 3.59%	18,570 $3.5 Million
Q4 2019 Feb 05, 2020	BUY	$71.7 - $82.09 $32,695 - $37,433	456 Added 2.42%	19,261 $4.49 Million
Q3 2019 Nov 04, 2019	SELL	$61.55 - $75.43 $62,473 - $76,561	-1,015 Reduced 5.12%	18,805 $4.14 Million
Q2 2019 Aug 01, 2019	SELL	$55.74 - $64.41 $70,845 - $81,865	-1,271 Reduced 6.03%	19,820 $3.66 Million
Q1 2019 May 08, 2019	BUY	$47.89 - $64.05 $35,151 - $47,012	734 Added 3.61%	21,091 $4.04 Million
Q4 2018 Jan 30, 2019	SELL	$46.41 - $56.94 $402,931 - $494,353	-8,682 Reduced 29.9%	20,357 $3.12 Million
Q3 2018 Nov 08, 2018	BUY	$45.7 - $58.03 $132,484 - $168,228	2,899 Added 11.09%	29,039 $5.06 Million
Q2 2018 Aug 08, 2018	BUY	$42.45 - $51.3 $5,603 - $6,771	132 Added 0.51%	26,140 $3.81 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $19,747 - $25,195	531 Added 2.08%	26,008 $3.63 Million
Q4 2017 Feb 08, 2018	SELL	$33.79 - $39.39 $297,352 - $346,632	-8,800 Reduced 25.67%	25,477 $2.87 Million
Q3 2017 Nov 02, 2017	BUY	$36.29 - $38.83 $101,140 - $108,219	2,787 Added 8.85%	34,277 $3.75 Million
Q2 2017 May 14, 2018	SELL	N/A	-9,578 Reduced 23.32%	31,490 $3.72 Million
Q1 2017 May 14, 2018	BUY	N/A	18,585 Added 82.66%	41,068 $3.86 Million
Q4 2016 May 14, 2018	BUY	N/A	22,483	22,483 $2.11 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Account

Keybank National Association Edwards Lifesciences Corp Transaction History